APIS · Recurrent Rectal Cancer
Recurrent Rectal Cancer: Local Treatment Review in Korea
When rectal cancer returns in the pelvis, further surgery may still be possible. If complete removal is not feasible, carbon-ion or proton therapy may be considered. Previous pelvic radiation and the position of the bowel are central to deciding whether radiation can be delivered safely.
What does locally recurrent rectal cancer mean?
It means rectal cancer has returned in the pelvis after earlier treatment. The recurrence may be near the previous operation site, pelvic wall, sacrum, bladder or nerves. Updated scans show whether it is confined to the pelvis or has also spread elsewhere. [1]
Surgical Review
Surgery may still be possible. A specialist pelvic surgery team reviews whether the recurrence can be completely removed and what loss of function or other risks the operation would involve. Previous surgery, scar tissue and invasion into surrounding structures can make this difficult. [1][2]
If surgery is not possible, the discussion may include radiation or re-irradiation, systemic treatment and symptom relief. The extent of the disease and the purpose of local treatment guide that discussion.
Previous Pelvic Radiation
Another course may be possible, but overlapping dose can injure bowel, bladder, nerves and pelvic tissues. Existing radiation injury, fistula, infection, the recurrence’s location and time since treatment affect the decision. [2][4]
Carbon-Ion and Proton Options
Carbon-ion therapy is used for some difficult-to-remove pelvic recurrences. Protons may also help reduce radiation beyond the tumor. The practical question is whether enough dose can reach the recurrence without giving too much to the bowel, bladder or nerves.
Yonsei’s August 19, 2026 Korean program update includes recurrent rectal cancer. Bowel touching or involved by the tumor can limit a safe treatment plan. [5]
How proton and carbon-ion treatment differ · Reviewing limited local-treatment options
Carbon-Ion Evidence
Published Japanese studies support review in carefully chosen patients with unresectable pelvic recurrence, including some who previously received radiation. These studies do not prove that carbon ions are better for every recurrence.
| Study | Reported outcome | Main limitation |
|---|---|---|
| Takiyama et al., 2024; recurrent colorectal cancer [3] | 5-year local control: 72% in 390 patients without previous radiation and 69% in 83 with previous radiation. | Retrospective groups with different histories; these are not randomized comparisons or Korean outcomes. |
| Yamada et al., 2022 (online 2021); 77 previously irradiated patients [4] | 5-year overall local control: 62%; 16 of 77 patients had grade 3 late toxicity. | Re-irradiation can cause serious harm. Cohorts from related centers and years may overlap; do not add them as independent evidence. |
Local control means control in the treated area, not freedom from distant spread. The receiving team should explain the expected benefit and the risk of bowel injury, fistula, infection or other complications.
Required Records for Hospital Review
For pelvic recurrence, helpful later additions are the original operation report, pathology, pelvic MRI or CT showing the recurrence, a surgeon’s opinion on whether it can be removed, and details of any stoma, obstruction, fistula or infection.
Include the previous pelvic radiation summary. DICOM-RT planning files may be needed to assess overlapping dose.
Treatment and Travel Planning
Tell the team about pain, bowel or urinary problems, stoma care and the support you need each day. Obstruction, infection or rapidly worsening symptoms may need care locally before travel.
The hospital determines the treatment course after reviewing the recurrence and prior pelvic dose. Before leaving home, agree who will manage stoma care, complications and continuing treatment.
Planning time, hospital costs and the stay in KoreaExplore Review for Pelvic Recurrence
Bring the questions about further surgery, previous pelvic radiation and symptom control.
Sources and dates
- National Cancer Institute, Rectal Cancer Treatment PDQ. Recurrent disease section.
- Miller et al., American Radium Society criteria for locoregionally recurrent rectal cancer. Cancer, 2026. doi:10.1002/cncr.70464.
- Takiyama et al., carbon-ion treatment for unresectable recurrent colorectal cancer. IJROBP, 2024;118:734–742. doi:10.1016/j.ijrobp.2023.09.036.
- Yamada et al., carbon-ion re-irradiation after pelvic radiation. Annals of Surgical Oncology, online October 18, 2021. doi:10.1245/s10434-021-10876-4.
- Yonsei Cancer Center program update, August 19, 2026. Hospital program information, separate from clinical-study evidence.
Content reviewed October 23, 2026.